Juliet Nabbuye Sekandi
Overview
Explore the profile of Juliet Nabbuye Sekandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sekandi J, Buregyeya E, Zalwango S, Nakkonde D, Kaggwa P, Quach T, et al.
JMIR Mhealth Uhealth
. 2024 Dec;
13:e57991.
PMID: 39715573
Background: Directly observed therapy (DOT) is the standard method for monitoring adherence to tuberculosis (TB) treatment. However, implementing DOT poses challenges for both patients and providers due to limited financial...
2.
Sekandi J, Shi W, Zhu R, Kaggwa P, Mwebaze E, Li S
JMIR AI
. 2024 Mar;
2(1):e40167.
PMID: 38464947
Background: Artificial intelligence (AI) applications based on advanced deep learning methods in image recognition tasks can increase efficiency in the monitoring of medication adherence through automation. AI has sparsely been...
3.
Sekandi J, McDonald A, Nakkonde D, Zalwango S, Kasiita V, Kaggwa P, et al.
JMIR Form Res
. 2023 Nov;
7:e46203.
PMID: 37948121
Background: In tuberculosis (TB) control, nonadherence to treatment persists as a barrier. The traditional method of ensuring adherence, that is, directly observed therapy, faces significant challenges that hinder its widespread...
4.
Sekandi J, Castellanos M, Woldu H, Kakaire R, Mutembo S, Mutanga J
PLoS One
. 2023 Feb;
18(2):e0280732.
PMID: 36730252
Introduction: Patient satisfaction is an important predictor of health outcomes among patients in HIV/AIDS treatment and care, yet it is rarely measured in routine clinic settings in most of Africa....
5.
Sekandi J, Murray K, Berryman C, Davis-Olwell P, Hurst C, Kakaire R, et al.
Interact J Med Res
. 2022 May;
11(1):e35062.
PMID: 35533323
Background: The exponential scale and pace of real-time data generated from mobile phones present opportunities for new insights and challenges across multiple sectors, including health care delivery and public health...
6.
Sekandi J, Kasiita V, Onuoha N, Zalwango S, Nakkonde D, Kaawa-Mafigiri D, et al.
JMIR Mhealth Uhealth
. 2021 Oct;
9(10):e27131.
PMID: 34704961
Background: Nonadherence to treatment remains a barrier to tuberculosis (TB) control. Directly observed therapy (DOT) is the standard for monitoring adherence to TB treatment worldwide, but its implementation is challenging,...
7.
Sekandi J, Onuoha N, Buregyeya E, Zalwango S, Kaggwa P, Nakkonde D, et al.
JMIR Res Protoc
. 2020 Sep;
10(1):e18029.
PMID: 32990629
Background: The World Health Organization's End TB Strategy envisions a world free of tuberculosis (TB)-free of deaths, disease, and suffering due to TB-by 2035. Nonadherence reduces cure rates, prolongs infectiousness,...
8.
Sekandi J, Sempeera H, List J, Whalen C
Pan Afr Med J
. 2012 Oct;
12:8.
PMID: 23077694
Contact investigation remains an essential component of tuberculosis (TB) control, yet missed opportunities to trace, medically examine, and treat close contacts of newly diagnosed index TB cases persist. We report...